Literature DB >> 34637330

NF-κB activation in cardiac fibroblasts results in the recruitment of inflammatory Ly6Chi monocytes in pressure-overloaded hearts.

Hajime Abe1, Yohei Tanada1, Shigemiki Omiya1, Mihai-Nicolae Podaru1, Tomokazu Murakawa1, Jumpei Ito1, Ajay M Shah1, Simon J Conway2, Masahiro Ono3, Kinya Otsu1,4.   

Abstract

Heart failure is a major public health problem, and inflammation is involved in its pathogenesis. Inflammatory Ly6Chi monocytes accumulate in mouse hearts after pressure overload and are detrimental to the heart; however, the types of cells that drive inflammatory cell recruitment remain uncertain. Here, we showed that a distinct subset of mouse cardiac fibroblasts became activated by pressure overload and recruited Ly6Chi monocytes to the heart. Single-cell sequencing analysis revealed that a subset of cardiac fibroblasts highly expressed genes transcriptionally activated by the transcription factor NF-κB, as well as C-C motif chemokine ligand 2 (Ccl2) mRNA, which encodes a major factor in Ly6Chi monocyte recruitment. The deletion of the NF-κB activator IKKβ in activated cardiac fibroblasts attenuated Ly6Chi monocyte recruitment and preserved cardiac function in mice subjected to pressure overload. Pseudotime analysis indicated two single-branch trajectories from quiescent fibroblasts into inflammatory fibroblasts and myofibroblasts. Our results provide insight into the mechanisms underlying cardiac inflammation and fibroblast-mediated inflammatory responses that could be therapeutically targeted to treat heart failure.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34637330     DOI: 10.1126/scisignal.abe4932

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  2 in total

1.  The heart under pressure: immune cells in fibrotic remodeling.

Authors:  Brandon Theall; Pilar Alcaide
Journal:  Curr Opin Physiol       Date:  2022-01-22

2.  SGLT2 inhibitor dapagliflozin reduces endothelial dysfunction and microvascular damage during cardiac ischemia/reperfusion injury through normalizing the XO-SERCA2-CaMKII-coffilin pathways.

Authors:  Li Ma; Rongjun Zou; Wanting Shi; Na Zhou; Shaoxian Chen; Hao Zhou; Xinxin Chen; Yueheng Wu
Journal:  Theranostics       Date:  2022-06-27       Impact factor: 11.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.